| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-N0565C |
| M.Wt: | 524.59 |
| Formula: | C22H24Ca2N2O8 |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
Doxycycline calcium is an orally active, broad-spectrum tetracycline antibiotic that also functions as an MMP inhibitor, exhibiting antibacterial, antiviral, antiparasitic, and antitumor activities. Doxycycline calcium can bind to the classical binding site (CBS) within the mRNA decoding center of the bacterial 70S ribosome's 30S small subunit.Doxycycline calcium blocks bacterial protein synthesis and inhibits the degradation of the extracellular matrix through its interaction with zinc and calcium ions. Doxycycline calcium also inhibits mitochondrial biogenesis, translation, and the expression of respiratory chain proteins. Doxycycline calcium induces apoptosis, inhibits autophagy and EMT, downregulates stem cell markers, and activates the PI3K-AKT pathway, thereby effectively inhibiting the viability and proliferation of cancer cells such as breast cancer cells. Doxycycline calcium can disrupt transthyretin (TTR) amyloid fibrils. Doxycycline calcium also promotes the survival and self-renewal of embryonic stem cells and neural stem cells, and reduces the frequency of medium changes in culture. Doxycycline calcium can be used in research related to cancers—such as breast, prostate, and bladder cancer—as well as neurological disorders[1][2][3][4][5][6][7][8][9][10].
In Vitro:Doxycycline (11.39 μM + MCF-7; 7.13 μM + MDA-MB-468; 72 h) calcium significantly reduces the population of CD44+/CD24-/low breast cancer stem cells in MCF-7 and MDA-MB-468 cells[2].
Doxycycline (11.39 μM+MCF-7; 7.13 μM+MDA-MB-468; 72 h) calcium significantly downregulates the mRNA and protein expression of stem cell markers (Nanog, Oct4, Sox2, c-Myc, CD44) in MCF-7 and MDA-MB-468 breast cancer cells[2].
Doxycycline (1 μg/mL; 5 d) calcium increases the colony formation efficiency of undifferentiated human embryonic stem cells (H9, HSF6, H1, H7, HUES6) and human induced pluripotent stem cells (retrovirus-derived, lentivirus-derived, protein-induced lines), and elevates the number of colonies expressing undifferentiated markers under various culture conditions[3].
Doxycycline (1 μg/mL; 5 d) calcium promotes the survival and proliferation of H9 human embryonic stem cells (hESC) more effectively than Y-27632 (HY-10071), resulting in larger cell colonies, a higher proportion of undifferentiated AP+ cells, as well as downregulated expression of pro-apoptotic genes and upregulated expression of pluripotency-related genes[3].
Doxycycline (1 μg/mL; 6 d; passage 12) calcium reduces cell apoptosis, increases S-phase cell accumulation, supports the long-term expansion of H9 human embryonic stem cells (H9 hESCs) and Lenti-1 induced pluripotent stem cells (Lenti-1 hiPSCs) cultured in clusters on MEF feeder layers, and maintains the pluripotency and normal karyotype of the cells during repeated passaging[3].
Doxycycline (1 μg/mL; 7 d) calcium maintains the viability, proliferation and expression of undifferentiated markers of H9 human embryonic stem cells for up to 7 days without medium change, and reduces apoptotic cell death of newly seeded dissociated cells and preformed cell clusters within 3 days without medium change[5].
Doxycycline (1 μg/mL; 30-72 d) calcium supports long-term subculture of H9, HSF6 human embryonic stem cells as well as Retro-1, Lenti-1, Pro-1 human induced pluripotent stem cells. The culture medium is replaced every 3 days, and the growth rate remains consistent with that under the standard daily medium change condition during passages 5 to 12[5].
Doxycycline (1 μg/mL; 72 d) calcium maintains normal karyotype, expression of undifferentiated markers and pluripotency (the ability to differentiate into all cells of the three germ layers in vitro) of H9 human embryonic stem cells that are subcultured 12 times with medium replacement every 3 days[5].
Doxycycline calcium binds to the classical binding site (CBS) within the mRNA decoding center of the bacterial 70S ribosome's 30S small subunit; through magnesium ion coordination, it hinders the binding of tRNA to the A-site[10].
In Vivo:Doxycycline (25-50 mg/kg; p.o.; twice daily; 10 days) calcium exerts dose-dependent toxic effects on male Wistar rats: a dosage of 50 mg/kg twice daily for 10 consecutive days causes 30% mortality, cardiomyopathy, and significant elevation of biomarkers for muscle and cardiac injury; whereas a dosage of 25 mg/kg twice daily for 10 consecutive days only induces mild skeletal muscle injury without cardiac toxicity[1].
Doxycycline (60 mg/kg; intraperitoneal injection; once daily for 15 consecutive days) calcium significantly inhibits the growth of CD44v9-expressing prostate cancer xenografts by reducing the proliferation of CD44v9-positive cells[4].
Supplementary culture of H9 human embryonic stem cells (H9 hESCs) with Doxycycline (1 μg/mL; medium changed every 3 days; up to passage 12) calcium maintains their pluripotency and enables in vivo teratoma formation, which contains all three embryonic germ layers[5].
Doxycycline (oral gavage; 200 or 800 mg/kg; once daily; 3 months) calcium reduces MMP-9 activity in untreated HT mice in a dose-dependent manner[3].
Doxycycline (40 mg/kg/day; oral administration; three months) calcium can disrupt transthyretin (TTR) amyloid fibrils and eliminate Congo red-positive amyloid deposits in a transgenic mouse model of familial amyloid polyneuropathy (FAP), without altering the deposition of non-fibrillar TTR. Furthermore, it reduces the levels of fibril-associated markers—such as MMP-9 and serum amyloid P component—in TTR-Met30Val × TTR-KO mice[9].
Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.